Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 12/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 11/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.48 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.47 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6016363 | 0.76 | LMNA (0.46) | NTRK1 | |
| SCHEMBL6016407 | 0.75 | KDM4E (0.48) | — | |
| SCHEMBL6016399 | 0.75 | ALDH1A1 (0.49) | — | |
| SCHEMBL6016362 | 0.73 | PTGS2 (0.45) | — | |
| SCHEMBL6016324 | 0.73 | CHRM5 (0.46) | NTRK1 | |
| SCHEMBL27488851 | 0.72 | LMNA (0.43) | — | |
| SCHEMBL6016349 | 0.72 | NTRK1 (0.45) | NTRK1 | |
| SCHEMBL28416685 | 0.72 | CYP19A1 (0.76) | CYP11B1CYP11B2CYP19A1TBXAS1 | |
| SCHEMBL6016470 | 0.71 | NTRK1 (0.42) | NTRK1 | |
| SCHEMBL6016450 | 0.71 | MEN1 (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1187815-B1 | 4-PHENYL-PYRIMIDINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2006-02-08 | — | — | EP | disclosed |
| CN-1166643-C | 4-phenyl-pyrimidine derivatives | - | 2004-09-15 | — | — | CN | disclosed |
| CN-1353697-A | 4-phenyl-pyrimidine derivatives | HOFFMANN LA ROCHE (CH) | 2002-06-12 | — | — | CN | disclosed |
| US-6274588-B1 | NEUROKININ OR SUBSTANCE P ANTAGONISTS; CENTRAL NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDES; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS | HOFFMANN-LA ROCHE INC. | 2001-08-14 | — | — | US | disclosed |